期刊
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
卷 12, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fcimb.2022.1010873
关键词
immune response; CD70; OX40L; adenoviral vectors; vaccine
资金
- Ministerio de Ciencia (Spain) [AGL2015-64290R, RTI2018-094616-B-100, PID2021-124872OB-I00]
- Comunidad de Madrid (Fondo Europeo de Desarrollo Regional, FEDER) [S2018/BAA-4370-PLATESA2]
This study investigates the immunomodulatory properties of OX40L and CD70 on the immune response to OVA antigen. The results show that OaCD70 administration can enhance the adaptive immune response to OVA, including increased antibody titers and the number of antigen-specific IgG-secreting B cells. Additionally, OaCD70 also promotes the differentiation and long-term activity of CD8(+) T cell effectors.
The tumour necrosis factor superfamily OX40L and CD70 and their receptors are costimulatory signalling axes critical for adequate T and B cell activation in humans and mice. In this work we inoculated groups of sheep with human recombinant adenovirus type 5 (Ad) expressing Ovis aries (Oa)OX40L or OaCD70 or a control adenoviral vector to determine whether they could improve the immune response to the model antigen OVA. PBMCs and serum samples were obtained for analysis of the adaptive immune response to OVA at days 0, 15, 30 and 90 post-inoculation (pi). Recall responses to OVA were assessed at day 7 and 30 after the second antigen inoculation (pb) at day 90. Administration of these immunomodulatory molecules did not induce unspecific PBMC stimulation. While OaOX40L administration mainly increased TNF-alpha and IL-4 in PBMC at day 15 pi concomitantly with a slight increase in antibody titer and the number of IFN-gamma producing cells, we detected greater effects on adaptive immunity after OaCD70 administration. AdOaCD70 inoculation improved antibody titers to OVA at days 30 and 90 pi, and increased anti-OVA-specific IgG-secreting B cell counts when compared to control. Moreover, higher IFN-gamma production was detected on days 7 pi, 7 pb and 30 pb in PBMCs from this group. Phenotypic analysis of T cell activation showed an increase in effector CD8(+) T cells (CD8(+) CD62L(-) CD27(-)) at day 15 pi in AdOaCD70 group, concurrent with a decrease in early activated cells (CD8(+) CD62L(-) CD27(+)). Moreover, recall anti-OVA CD8(+) T cell responses were increased at 7 pb in the AdOaCD70 group. AdOaCD70 administration could therefore promote CD8(+) T cell effector differentiation and long-term activity. In this work we characterized the in vivo adjuvant potential on the humoral and cellular immune response of OaOX40L and OaCD70 delivered by non-replicative adenovirus vectors using the model antigen OVA. We present data highlighting the potency of these molecules as veterinary vaccine adjuvant.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据